Development and progression of gastroesophageal varices in patients with chronic hepatitis C

References

• Fontana RJ, Sanyal AJ, Ghany MG et al. Factors that determine the development and progression of gastroesophageal varices in patients with chronic hepatitis C. Gastroenterology138(7), 2321–2331 (2010).
   PubMed Web of Science ®Google Scholar
• Carbonell N, Pauwels A, Serfaty L, Fourdan O, Levy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology40, 652–659 (2004).
   PubMed Web of Science ®Google Scholar
• Bosch J, Berzigotti A, Garcia-Pagan JC, Abraldes JG. The management of portal hypertension: rational basis, available treatments and future options. J. Hepatol.48(Suppl. 1), S68–S92 (2008).
   PubMed Web of Science ®Google Scholar
• Garcia-Tsao G, Sanyal AJ, Grace ND, Carey WD; Practice Guidelines Committee of American Association for Study of Liver Diseases; Practice Parameters Committee of American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology46, 922–938 (2007).
   PubMed Web of Science ®Google Scholar
• de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J. Hepatol.43, 167–176 (2005).
   PubMed Web of Science ®Google Scholar
• Thabut D, Trabut JB, Massard J et al. Non-invasive diagnosis of large oesophageal varices with FibroTest in patients with cirrhosis: a preliminary retrospective study. Liver Int.26, 271–278 (2006).
   PubMed Web of Science ®Google Scholar
• Gentile I, Viola C, Graf M et al. A simple noninvasive score predicts gastroesophageal varices in patients with chronic viral hepatitis. J. Clin. Gastroenterol.43, 81–87 (2008).
   Web of Science ®Google Scholar
• Berzigotti A, Gilabert R, Abraldes JG et al. Noninvasive prediction of clinically significant portal hypertension and esophageal varices in patients with compensated liver cirrhosis. Am. J. Gastroenterol.103, 1159–1167 (2008).
   PubMed Web of Science ®Google Scholar
• Giannini EG, Zaman A, Kreil A et al. Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study. Am. J. Gastroenterol.101, 2511–2519 (2006).
   PubMed Web of Science ®Google Scholar
• Kazemi F, Kettaneh A, N’Kontchou G et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J. Hepatol.45, 230–235 (2006).
   PubMed Web of Science ®Google Scholar
• Vizzutti F, Arena U, Romanelli RG et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology45, 1290–1297 (2007).
   PubMed Web of Science ®Google Scholar
• Zaman A, Becker T, Lapidus J, Benner K. Risk factors for the presence of varices in cirrhosis without a history of variceal hemorrhage. Arch. Intern. Med.161, 2564–2570 (2001).
   PubMedGoogle Scholar
• Thomopoulos KC, Labropoulou-Karatza C, Mimidis KP, Katsakoulis EC, Iconomou G, Nikolopoulou VN. Non-invasive predictors of the presence of large esophageal varices in patients with cirrhosis. Dig. Liver Dis.35, 473–478 (2003).
   PubMedGoogle Scholar
• Schepis F, Camma C, Niceforo D et al. Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? Hepatology33, 333–338 (2001).
   PubMed Web of Science ®Google Scholar
• Madhotra R, Mulcahy H, Willner I, Reuben A. Prediction of esophageal varices in patients with cirrhosis. J. Clin. Gastroenterol.34, 81–85 (2002).
   PubMed Web of Science ®Google Scholar
• Pilette C, Oberti F, Aube C et al. Non-invasive diagnosis of esophageal varices in chronic liver disease. J. Hepatol.31, 867–873 (1999).
   PubMed Web of Science ®Google Scholar
• Chalasani N, Imperiale TF, Ismail A et al. Predictors of large esophageal varices in patients with cirrhosis. Am. J. Gastroenterol.94, 3285–3291 (1999).
   PubMed Web of Science ®Google Scholar
• Di Bisceglie AM, Shiffman ML, Everson GT et al. Prolonged therapy of advanced chronic hepatitis C with low dose peginterferon. N. Engl. J. Med.359, 2429–2441 (2008).
   PubMed Web of Science ®Google Scholar
• Cardenas A, Pritchett S, Brown RS, Levin RA, Curry MP, Afdhal NH. The effects of long-term PEG-interferon therapy on the development of esophageal varices and variceal bleeding in patients with chronic hepatitis C and advanced fibrosis: final results from the CoPilot Trial. Gastroenterology136(Suppl. 1), abstract 259 (2009).
   Google Scholar
• Lepe R, Layden-Almer JE, Layden TJ, Cotler S. Ethnic differences in the presentation of chronic hepatitis C. J. Viral Hepat.13, 116–120 (2006).
   PubMed Web of Science ®Google Scholar
• Tencate V, Layden-Almer JE, Wolfert M et al. Paired biopsies illustrate racial differences in fibrosis progression in HCV patients. Hepatology50(Suppl. 1), abstract 1629 (2009).
   Google Scholar
• Rodriguez-Torres M, Jeffers LJ, Sheikh MY et al. Peginterferon alfa-2a and ribavirin in Latino and non-Latino whites with hepatitis C. N. Engl. J. Med.360, 257–267 (2009).
   PubMed Web of Science ®Google Scholar
• Lok ASF, Ghany MG, Goodman ZD et al. Predicting cirrhosis in patients with chronic hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatology38, 518–526 (2005).
   Web of Science ®Google Scholar